2014 Dec


1. The Notch intracellular domain represses CRE-dependent transcription. Cell Signal. 2014 Dec 2. pii: S0898-6568(14)00388-X.

3. Impact of socioeconomic status on initial clinical presentation to a memory disorders clinic. Int Psychogeriatr. 2014 Apr;26(4):597-603.

5. Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes. J Neuropathol Exp Neurol. 2014 Apr;73(4):295-304.

7. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection. Neurosci Lett. 2014 Jul 25;576:73-8.

9. Ordered subset analysis of copy number variation association with age at onset of Alzheimer’s disease. J Alzheimers Dis. 2014;41(4):1063-71.

11. Frontal white matter integrity in adults with Down syndrome with and without dementia. Neurobiol Aging. 2014 Jul;35(7):1562-9.

14. Confrontation Naming Errors in Alzheimer’s Disease. Dement Geriatr Cogn Disord. 2014;37(1-2):86-94.

15. Firing properties of entorhinal cortex neurons and early alterations in an Alzheimer’s disease transgenic model. Pflugers Arch. 2014 Jul;466(7):1437-50.

16. Multipotent, Permeable Drug ASS234 Inhibits Aβ Aggregation, Possesses Antioxidant properties and Protects from Aβ-induced Apoptosis In vitro. Current Alzheimer Research 2013, 9, 797-808

18. Davunetide: Peptide therapeutic in neurological disorders. Curr Med Chem. 2014;21(23):2591-8.

20. Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease. MAbs. 2013 Sep-Oct;5(5):665-77.

22. Fungal infection in patients with Alzheimer’s disease. J Alzheimers Dis. 2014;41(1):301-11.

Platelets_BDNF_decline24. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer’s disease and depression. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:83-93.



2. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease. Nature. 2014 Jan 23;505(7484):550-4.

4. Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity. Neurobiol Aging. 2014 Sep;35(9):2064-71.

6. EEG upper/low alpha frequency power ratio and the impulsive disorders network in subjects with mild cognitive impairment. Curr Alzheimer Res. 2014 Feb;11(2):192-9.

8. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency. J Med Chem. 2014 Aug 14;57(15):6679-703.

10. Involvement of TRPV4 channels in 40-induced hippocampal cell death and astrocytic Ca2+ signaling. Neurotoxicology. 2014 Mar;41:64-72.

12. Association of the variant Cys139Arg at GRN gene to the clinical spectrum of frontotemporal lobar degeneration. J Alzheimers Dis. 2014;40(3):679-85.

fig117. Proteomic analysis of serum proteins in triple transgenic Alzheimer’s disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer’s disease. J Alzheimers Dis. 2014;40(3):575-86.

19. Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer’s disease. Neurochem Res. 2014 Jun;39(6):1171-81.

21. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol. 2014 Apr;254:78-89.

fig125. Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies. Nanomedicine. 2014 Apr;9(5):709-22.





Multiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier SchönmannMultiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier Schönmann